Skip to search formSkip to main contentSkip to account menu

ganstigmine

Known as: (-)-O-((2'-ethylphenyl)carbamoyl)geneseroline hydrochloride, (4AS,9AS)-2,3,4,4a,9,9a-Hexahydro-2,4a,9-Trimethyl-1,2-Oxazino(6,5-B)Indol-6-Yl O-Ethylcarbanilate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Summary. We have investigated the effect of ganstigmine (CHF2819), a novel geneserine derived acetylcholinesterase (AChE… 
2003
2003
In order to deepen the understanding of the metabolism of Ganstigmine, a new acetylcholinesterase inhibitor under evaluation for… 
2003
2003
The objective of this study was to evaluate the safety, tolerability, maximum tolerated dose, pharmacokinetics, and… 
Review
2003
Review
2003
Ganstigmine (CHF-2819) is being developed by Chiesi as a potential treatment for neurodegenerative and cognitive disorders. The… 
Review
2002
Review
2002
2001
2001
Ganstigmine, a new acetylcholinesterase inhibitor, was incubated with rat liver microsomes and the resulting metabolites were…